biOasis Technologies, Inc. operates as a biopharmaceutical company. It focuses on research and development for the diagnosis and treatment of neurological disease and disorders such as brain cancers, neurodegenerative diseases, and metabolic disorders. Its products include the Transcend program as its proprietary carrier, p97 and imaging agents across the blood brain barrier. The company was founded by Robin B. Hutchison on November 3, 2006 and is headquartered in New Haven, CT.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A
Frequently Asked Questions
What is the 52-week high for Bioasis Technologies Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Bioasis Technologies Inc 52 week high is $0.0006 as of February 25, 2026.
What was Bioasis Technologies Inc stock price yesterday?
Bioasis Technologies Inc stock price yesterday was $0.0002.